Jason S O'Neill from San Bernardino, CA, age 43

Name / Title

Company / Classification

Phones & Addresses

Jason O'neill
Director, President

Forney Pee Wee Association

view source

Industry:

Food Production

Work:

Tasty Baking Company
Route Sales

Skills:

Direct Store Delivery

view source

view source

Location:

Greater Seattle Area

Industry:

Construction

view source

Location:

Greater Seattle Area

Industry:

Building Materials

Human Il-23 Antigen Binding Proteins
view source
US Patent:

20130004501, Jan 3, 2013
Filed:

Oct 26, 2010
Appl. No.:

13/504449
Inventors:

Jennifer E. Towne - Seattle WA, US
Janet D. Cheng - Seattle WA, US
Jason C. O'Neill - Brier WA, US
Yu Zhang - Shoreline WA, US
Yu Sun - Seattle WA, US
Heather Cerne - Seattle WA, US
Derek E. Piper - Santa Clara CA, US
Randal R. Ketchem - Snohomish WA, US
Assignee:

Amgen Inc. - Thousand Oaks CA
International Classification:

A61K 39/395
C12N 15/63
C07K 16/24
C12N 1/19
C12N 5/10
C12P 21/02
C12N 15/13
C12N 1/21
US Classification:

4241391, 536 2353, 4353201, 43525233, 4352542, 435331, 435 696, 5303879
Abstract:

Antigen binding proteins that bind to human IL-23 protein are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same as well as use of IL-23 antigen binding proteins for diagnostic and therapeutic purposes are also provided.

Activin Receptor Type Ii Chimeras And Methods Of Use Thereof
view source
US Patent:

20230079602, Mar 16, 2023
Filed:

Sep 15, 2022
Appl. No.:

17/945299
Inventors:

- Lexington MA, US
Jennifer LACHEY - Lincoln MA, US
Claire TSENG - Newton MA, US
Jason O'NEILL - Lake Forest Park WA, US
Henning THØGERSEN - Farum, DK
Elissa FURUTANI - Belmont MA, US
International Classification:

C07K 14/71
A61P 21/00
A61P 19/08
A61P 7/06
A61P 11/00
A61P 3/04
A61P 7/04
A61P 7/00
Abstract:

The invention features polypeptides that include an extracellular ActRII chimera. In some embodiments, a polypeptide of the invention includes an extracellular ActRII chimera fused to an Fc domain monomer or moiety. The invention also features pharmaceutical compositions and methods of using the polypeptides to treat diseases and conditions involving weakness and atrophy of muscles, bone damage, low red blood cell levels (e.g., anemia or blood loss), low platelet levels (e.g., thrombocytopenia), low neutrophil levels (e.g., neutropenia), fibrosis, metabolic disorders, and/or pulmonary hypertension.

Human Il-23 Antigen Binding Proteins
view source
US Patent:

20210024626, Jan 28, 2021
Filed:

Oct 1, 2020
Appl. No.:

17/060905
Inventors:

- Thousand Oaks CA, US
Janet D. Cheng - Montclair CA, US
Jason C. O'Neill - Brier WA, US
Yu Zhang - Shoreline WA, US
Yu Sun - Seattle WA, US
Heather Cerne - Seattle WA, US
Derek E. Piper - Santa Clara CA, US
Randal R. Ketchem - Snohomish WA, US
International Classification:

C07K 16/24
A61K 47/68
A61K 39/395
Abstract:

Antigen binding proteins that bind to human IL-23 protein are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same as well as use of IL-23 antigen binding proteins for diagnostic and therapeutic purposes are also provided.

Human Il-23 Antigen Binding Proteins
view source
US Patent:

20200181255, Jun 11, 2020
Filed:

Feb 18, 2020
Appl. No.:

16/793610
Inventors:

- Thousand Oaks CA, US
Janet D. Cheng - Seattle WA, US
Jason C. O'Neill - Brier WA, US
Yu Zhang - Shoreline WA, US
Yu Sun - Seattle WA, US
Heather Cerne - Seattle WA, US
Derek E. Piper - Santa Clara CA, US
Randal R. Ketchem - Snohomish WA, US
International Classification:

C07K 16/24
A61K 39/395
A61K 47/68
Abstract:

Antigen binding proteins that bind to human IL-23 protein are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same as well as use of IL-23 antigen binding proteins for diagnostic and therapeutic purposes are also provided.

Human Il-23 Antigen Binding Proteins
view source
US Patent:

20190322737, Oct 24, 2019
Filed:

Jun 26, 2019
Appl. No.:

16/453482
Inventors:

- Thousand Oaks CA, US
Janet D. Cheng - Seattle WA, US
Jason C. O'Neill - Brier WA, US
Yu Zhang - Shoreline WA, US
Yu Sun - Seattle WA, US
Heather Cerne - Seattle WA, US
Derek E. Piper - Santa Clara CA, US
Randal R. Ketchem - Snohomish WA, US
International Classification:

C07K 16/24
A61K 39/395
A61K 47/68
Abstract:

Antigen binding proteins that bind to human IL-23 protein are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same as well as use of IL-23 antigen binding proteins for diagnostic and therapeutic purposes are also provided.

Variants Of Tissue Inhibitor Of Metalloproteinase Type Three (Timp-3), Compositions And Methods
view source
US Patent:

20190085054, Mar 21, 2019
Filed:

Dec 4, 2018
Appl. No.:

16/209239
Inventors:

- Thousand Oaks CA, US
Jason Charles O'Neill - Brier WA, US
Randal R. Ketchem - Snohomish WA, US
Randy Ira Hecht - Raleigh NC, US
Edward J. Belouski - Thousand Oaks CA, US
Mark Leo Michaels - Encino CA, US
International Classification:

C07K 14/81
C12N 9/64
A61K 38/00
Abstract:

There are disclosed TIMP-3 muteins, variants and derivatives, nucleic acids encoding them, and methods of making and using them.

Human Il-23 Antigen Binding Proteins
view source
US Patent:

20190071498, Mar 7, 2019
Filed:

Nov 19, 2018
Appl. No.:

16/194896
Inventors:

- Thousand Oaks CA, US
Janet D. Cheng - Seattle WA, US
Jason C. O'Neill - Brier WA, US
Yu Zhang - Shoreline WA, US
Yu Sun - Seattle WA, US
Heather Cerne - Seattle WA, US
Derek E. Piper - Santa Clara CA, US
Randal R. Ketchem - Snohomish WA, US
International Classification:

C07K 16/24
A61K 39/395
A61K 47/68
A61K 39/00
Abstract:

Antigen binding proteins that bind to human IL-23 protein arc provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same as well as use of IL-23 antigen binding proteins for diagnostic and therapeutic purposes arc also provided.

Gitr Antigen Binding Proteins
view source
US Patent:

20170022285, Jan 26, 2017
Filed:

Oct 10, 2016
Appl. No.:

15/289797
Inventors:

- THOUSAND OAKS CA, US
Jason C. O'NEILL - BRIER WA, US
Ian FOLTZ - BURNABY, CA
Randall R. KETCHEM - SNOHOMISH WA, US
Julia C. PIASECKI - SEATTLE WA, US
Assignee:

AMGEN INC. - THOUSAND OAKS CA
International Classification:

C07K 16/28
Abstract:

Antigen binding proteins that activate GITR are provided. Nucleic acids encoding the antigen binding proteins and vectors and cells containing such nucleic acids are also provided. The antigen binding proteins have value in therapeutic methods in which it is useful to stimulate GITR signaling, thereby inducing or enhancing an immune response in a subject. Accordingly, the antigen binding proteins have utility in a variety of immunotherapy treatments, including treatment of various cancers and infections.